Pancreapar

Manufacturer
Energique, Inc. | Apotheca Company
Effective date
2023-08-24
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 02:22:08

Label at a glance#

ProductPancreapar
Active ingredientSYZYGIUM CUMINI SEED, SUS SCROFA ADRENAL GLAND, GOLDENSEAL, SUS SCROFA PITUITARY GLAND, SUS SCROFA PANCREAS, KIDNEY BEAN, ACETIC ACID, LACTIC ACID, PHOSPHORIC ACID, PHOSPHORUS, URANYL NITRATE HEXAHYDRATE
Label structure9 sections

Dosage and administration

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

(in each drop): 9.99% of Aceticum Acidum 12X, Glandula Suprarenalis Suis 6X, Hydrastis Canadensis 6X, Hypophysis Suis 6X, Lacticum Acidum 12X, Pancreas Suis 6X, Phaseolus 9X, Phosphorus 12X, Phosphoricum Acidum 12X, Uranium Nitricum 12X; 0.10% of Syzygium Jambolanum 3X.

INDICATIONS:

OTC - PURPOSE SECTION

May temporarily relieve thirst, weakness and feebleness with weight loss, frequent urination, and weakness and fatigue with lethargy.

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

WARNINGS:

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

INDICATIONS:

INDICATIONS & USAGE SECTION

May temporarily relieve thirst, weakness and feebleness with weight loss, frequent urination, and weakness and fatigue with lethargy.

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Demineralized water, 20% Ethanol.

QUESTIONS:

OTC - QUESTIONS SECTION

Dist. by Energique, Inc.

201 Apple Blvd

Woodbine, IA 51579   800.869.8078

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ENERGIQUE
SINCE 1987
HOMEOPATHIC REMEDY
PANCREAPAR
1 fl. oz. (30 ml)

PancreaparPancreapar

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0420-12023-08-24C16284748780-1ba0f9c33-1e71-a910-e053-dadaa90a0b85Drug Facts:
44911-0420-12023-01-30C16284748780-1ba0f9c33-1e71-a910-e053-dadaa90a0b85Drug Facts:
44911-0420-12021-10-01C16284748780-1ba0f9c33-1e71-a910-e053-dadaa90a0b85Drug Facts:
44911-0420-12021-01-29C16284748780-1ba0f9c33-1e71-a910-e053-dadaa90a0b85Drug Facts:

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
44911-0420-1Pancreapar30 mL in 1 BOTTLE, DROPPERLIQUID306

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
44911-0420PANCREAPAR (SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM) LIQUID [ENERGIQUE, INC.]6Current NDC, Legacy NDC, 1 package rows20230825_ba9c13d0-92de-4159-8a35-215e3de50c07.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
44911-042044911-0420-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PancreaparSYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUMEnergique, Inc.ba9c13d0-92de-4159-8a35-215e3de50c072023-08-24WarningsExact identifier
ndc (package): 44911-0420-1
ndc (product): 44911-0420
ndc11 (package): 44911042001
spl id: c2dcad60-9715-4366-af68-043bcc679745
spl set id: ba9c13d0-92de-4159-8a35-215e3de50c07

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.